Hunan, China

Shishi Luo

This inventor holds 1 USPTO granted patent. Top assignee: University of South China. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shishi Luo. Retrieved from https://idiyas.com/inventor/shishi-luo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shishi Luo: Innovator in Anti-Epileptic Drug Development

Introduction

Shishi Luo is a prominent inventor based in Hunan, China. She has made significant contributions to the field of pharmacology, particularly in the development of anti-epileptic drugs. Her innovative work focuses on the use of specific inhibitors to enhance treatment options for epilepsy.

Latest Patents

Shishi Luo holds a patent for the "Use of I-BRD9 or derivatives thereof in preparing anti-epileptic drugs." This patent outlines methods for utilizing bromodomain-containing protein 9 inhibitor (I-BRD9) or its derivatives in the preparation of anti-epileptic medications. The findings indicate that I-BRD9 has substantial effects on anticonvulsion, prolonging convulsion latency, and reducing seizure levels. This research opens new avenues for developing effective anti-epileptic drug preparations.

Career Highlights

Shishi Luo is affiliated with the University of South China, where she continues her research and development efforts. Her work has garnered attention for its potential impact on improving the quality of life for individuals suffering from epilepsy.

Collaborations

Shishi collaborates with notable colleagues, including Wenyu Cao and Yang Xu. Their combined expertise contributes to advancing research in the field of anti-epileptic drug development.

Conclusion

Shishi Luo's innovative contributions to anti-epileptic drug development highlight her role as a key inventor in the pharmaceutical industry. Her research not only enhances treatment options but also demonstrates the importance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…